Results 51 to 60 of about 4,182 (143)

Safety Profile of Homologous and Heterologous Booster COVID-19 Vaccines in Physicians in Quito-Ecuador: A Cross-Sectional Study

open access: yesVaccines, 2023
More than 600 healthcare workers died due to COVID-19 infection until January 2022 in Ecuador. Even though the COVID-19 vaccines are safe, local and systemic reactions were reported among physicians. This study aims to analyze the adverse events of COVID-
Nancy Flores-Lastra   +6 more
doaj   +1 more source

Respiratory virus mRNA vaccines: mRNA Design, clinical studies, and future challenges

open access: yesAnimal Models and Experimental Medicine, Volume 8, Issue 10, Page 1731-1740, October 2025.
Abstract Respiratory infectious diseases frequently erupt on a global scale, with RNA viruses, such as SARS‐CoV‐2, RSV, and influenza viruses, posing challenges to vaccine development due to their high mutation rates. Traditional vaccine development cycles are lengthy and struggle to keep pace with rapidly evolving viruses, whereas messenger RNA (mRNA)
Linlin Zheng, Han Feng
wiley   +1 more source

Recovery from Myalgic Encephalomyelitis/Chronic Fatigue syndrome developed after severe acute respiratory syndrome coronavirus 2 vaccination: A case report

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 2, June 2025.
Abstract Background Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a neurological adverse effect after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccinations. However, clinicians do not recognize the condition well, and no case report has shown a full recovery.
Isaku Kurotori   +2 more
wiley   +1 more source

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

open access: yesJournal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi   +4 more
wiley   +1 more source

Blood transcriptome profiling reveals distinct gene networks induced by mRNA vaccination against COVID‐19

open access: yesEuropean Journal of Immunology, Volume 54, Issue 11, November 2024.
Using an unsupervised weighted gene correlation analysis on blood transcriptomes pre‐ and post‐COVID‐19 mRNA vaccination, we identify distinct gene networks that are up‐ and downregulated in response to vaccination. A particular interferon‐associated network significantly correlated with induced antibody levels and was further characterized, for ...
Lennart Riemann   +11 more
wiley   +1 more source

Morbidity and Mortality Weekly Report (MMWR)

open access: yes
Nursing home residents have experienced disproportionally high levels of COVID-19-associated morbidity and Mortality and were prioritized for early COVID-19 vaccination (1).

core   +2 more sources

Emerg Infect Dis

open access: yes
We assessed effectiveness of the BNT162b2 vaccine against infection with the B.1.1.529 (Omicron) variant (mostly BA.1 subvariant), among children 5-11 years of age in Israel.

core   +3 more sources

Pfizer-BioNTech COVID-19 vaccine : standing orders for administering vaccine : 12 years of age and older (purple cap)

open access: yes
To reduce morbidity and mortality from coronavirus disease 2019 (COVID-19) by vaccinating persons who meet the criteria established by the Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization Practices (ACIP).CS321570 ...

core   +3 more sources

Strong and early immune responses against SARS-CoV-2 in mice and rhesus macaques after BNT162b3 vaccination

open access: yesnpj Vaccines
We preclinically characterize BNT162b3, a nucleoside-modified mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding a trimerized, cell surface-tethered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain ...
Annette B. Vogel   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy